Search Results - "Current pharmaceutical biotechnology"
-
1
CAR T-cell Therapy: A New Era in Cancer Immunotherapy
Published in Current pharmaceutical biotechnology (01-01-2018)“…Cancer is one of the leading causes of death worldwide. Over the years, a number of conventional cytotoxic approaches for neoplastic diseases has been…”
Get more information
Journal Article -
2
Cell Proliferation and Cytotoxicity Assays
Published in Current pharmaceutical biotechnology (01-11-2016)“…Cell viability is defined as the number of healthy cells in a sample and proliferation of cells is a vital indicator for understanding the mechanisms in action…”
Get more information
Journal Article -
3
miRNA and cancer; computational and experimental approaches
Published in Current pharmaceutical biotechnology (01-01-2014)“…Human genome sequencing was started to solve four letter algorithm of the genome to understand the complex nature of human metabolism. However, after…”
Get more information
Journal Article -
4
Microbial Enzymatic Degradation of Biodegradable Plastics
Published in Current pharmaceutical biotechnology (01-04-2017)“…The renewable feedstock derived biodegradable plastics are important in various industries such as packaging, agricultural, paper coating, garbage bags and…”
Get more information
Journal Article -
5
The Critical Role of Abnormal Trophoblast Development in the Etiology of Preeclampsia
Published in Current pharmaceutical biotechnology (01-01-2018)“…The pregnancy pathology preeclampsia is still among the leading causes of maternal and perinatal morbidity and mortality. At the same time, its etiology is far…”
Get more information
Journal Article -
6
Wound Healing Effects of Curcumin: A Short Review
Published in Current pharmaceutical biotechnology (01-09-2016)“…Wound healing is a complex process that consists of several phases that range from coagulation, inflammation, accumulation of radical substances, to…”
Get more information
Journal Article -
7
Clinical Applications of Personalized Medicine: A New Paradigm and Challenge
Published in Current pharmaceutical biotechnology (01-03-2017)“…The personalized medicine is an emergent and rapidly developing method of clinical practice that uses new technologies to provide decisions in regard to the…”
Get more information
Journal Article -
8
Potential Pharmaceutical and Food Applications of Postbiotics: A Review
Published in Current pharmaceutical biotechnology (01-01-2020)“…In recent decades, functional foods with ingredients comprising probiotics, prebiotics and postbiotics have been gaining a lot of attention from scientists…”
Get more information
Journal Article -
9
Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF)
Published in Current pharmaceutical biotechnology (01-06-2012)“…Platelet concentrates for surgical use are tools of regenerative medicine designed for the local release of platelet growth factors into a surgical or wounded…”
Get more information
Journal Article -
10
Polyphenols: well beyond the antioxidant capacity: gallic acid and related compounds as neuroprotective agents: you are what you eat
Published in Current pharmaceutical biotechnology (01-01-2014)“…Gallic acid (3,4,5-trihydroxybenzoic acid) is a phenolic acid widely distributed in many different families of higher plants, both in free state, and as a part…”
Get more information
Journal Article -
11
Sports medicine applications of platelet rich plasma
Published in Current pharmaceutical biotechnology (01-06-2012)“…Platelet rich plasma (PRP) is a powerful new biologic tool in sports medicine. PRP is a fraction of autologous whole blood containing and increased number of…”
Get more information
Journal Article -
12
A review on the toxicity and non-target effects of macrocyclic lactones in terrestrial and aquatic environments
Published in Current pharmaceutical biotechnology (01-05-2012)“…The avermectins, milbemycins and spinosyns are collectively referred to as macrocyclic lactones (MLs) which comprise several classes of chemicals derived from…”
Get more information
Journal Article -
13
Lipid metabolism during pregnancy and its implications for fetal growth
Published in Current pharmaceutical biotechnology (01-01-2014)“…More glucose crosses the placenta than any other substrate, but correlations between its concentration in maternal plasma and fetal growth are not found…”
Get more information
Journal Article -
14
The potential of microalgae for the production of bioactive molecules of pharmaceutical interest
Published in Current pharmaceutical biotechnology (01-12-2012)“…Through the photosynthetic activity, microalgae process more than 25% of annual inorganic carbon dissolved in oceans into carbohydrates that ultimately, serve…”
Get more information
Journal Article -
15
Naringenin and its Nano-formulations for Fatty Liver: Cellular Modes of Action and Clinical Perspective
Published in Current pharmaceutical biotechnology (01-01-2018)“…Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease mainly caused by high-fat diets and sudden feed changes, vitamin and energy…”
Get more information
Journal Article -
16
Hairy Root Culture an Alternative for Bioactive Compound Production from Medicinal Plants
Published in Current pharmaceutical biotechnology (01-01-2021)“…Medicinal plants produce a diverse group of phytocompounds like anthraquinones, alkaloids, anthocyanins, flavonoids, saponins, and terpenes which are used in…”
Get more information
Journal Article -
17
Phage therapy in clinical practice: treatment of human infections
Published in Current pharmaceutical biotechnology (01-01-2010)“…Phage therapy is the application of bacteria-specific viruses with the goal of reducing or eliminating pathogenic or nuisance bacteria. While phage therapy has…”
Get more information
Journal Article -
18
The role of dietary polyphenols in the management of inflammatory bowel disease
Published in Current pharmaceutical biotechnology (01-01-2015)“…Inflammatory bowel disease (IBD) is an idiopathic chronic, relapsing inflammation of the bowel which is caused by dysregulation of the mucosal immune system…”
Get more information
Journal Article -
19
Non-viral gene delivery methods
Published in Current pharmaceutical biotechnology (2013)“…Gene delivery has attracted increasing interest as a highly promising therapeutic method to treat various diseases, including both genetic and acquired…”
Get more information
Journal Article -
20
Staphylococcus aureus : Biofilm Formation and Strategies Against it
Published in Current pharmaceutical biotechnology (01-01-2022)“…Formation of Staphylococcus aureus biofilm causes significant infections in the human body. Biofilm forms through the aggregation of bacterial species and…”
Get more information
Journal Article